Literature DB >> 1413490

Localization of thromboxane synthase in human tissues by monoclonal antibody Tü 300.

R Nüsing1, G Sauter, P Fehr, U Dürmüller, M Kasper, F Gudat, V Ullrich.   

Abstract

Using the monoclonal antibody Tü 300 we localized thromboxane synthase, a secondary enzyme of the arachidonic acid cascade, employing the alkaline phosphatase anti-alkaline phosphatase method and indirect double labelling immunofluorescence in frozen sections of human tissues. Aside from platelets, the source of the antigen, all cells of the mononuclear phagocytic system were positive, including epithelioid cells and associated giant cells, starry sky macrophages, dendritic cells of T-cell areas, Langerhans cells and Kupffer cells. In addition, some epithelial cells such as epithelia of tonsillar crypts, reticular epithelia of the thymic cortex and ductular epithelia in liver, pancreas, female breast and salivary glands showed occasional focal reactivity for thromboxane synthase. We suggest that the mAb Tü 300 is a key marker for the macrophage system and the thromboxane generating system in normal and pathological conditions. It may detect functional activities of as yet unknown significance in some specialized epithelial cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1413490     DOI: 10.1007/bf01611182

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  22 in total

1.  Tumour cell proliferation by thromboxane A2: a receptor-mediated event.

Authors:  S Nigam; A Zakrzewicz
Journal:  Adv Prostaglandin Thromboxane Leukot Res       Date:  1991

2.  Immunoquantitation of thromboxane synthase in human tissues.

Authors:  R Nüsing; V Ullrich
Journal:  Eicosanoids       Date:  1990

3.  Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides.

Authors:  P Needleman; S Moncada; S Bunting; J R Vane; M Hamberg; B Samuelsson
Journal:  Nature       Date:  1976-06-17       Impact factor: 49.962

4.  Production and characterization of polyclonal and monoclonal antibodies against human thromboxane synthase.

Authors:  R Nüsing; M P Wernet; V Ullrich
Journal:  Blood       Date:  1990-07-01       Impact factor: 22.113

5.  Cardiopulmonary function as related to thromboxane A2 synthesis in experimental septic shock.

Authors:  K M Schützer; E Lindholm; U Haglund; A Falk
Journal:  Circ Shock       Date:  1988-09

Review 6.  Thromboxane A2 in cardiovascular and renal disorders: is there a defined role for thromboxane receptor antagonists or thromboxane synthase inhibitors?

Authors:  E F Smith
Journal:  Eicosanoids       Date:  1989

7.  Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2.

Authors:  E F Ellis; O Oelz; L J Roberts; N A Payne; B J Sweetman; A S Nies; J A Oates
Journal:  Science       Date:  1976-09-17       Impact factor: 47.728

8.  Urine i-TXB2 in renal allograft rejection.

Authors:  M L Foegh; J F Winchester; M Zmudka; G B Helfrich; C Cooley; P W Ramwell; G E Schreiner
Journal:  Lancet       Date:  1981-08-29       Impact factor: 79.321

Review 9.  The Langerhans cell.

Authors:  G Rowden
Journal:  Crit Rev Immunol       Date:  1981-12       Impact factor: 2.214

10.  Selective inhibition of thromboxane biosynthesis in human blood mononuclear cells and the effects of mitogen-stimulated lymphocyte proliferation.

Authors:  D Gordon; A M Nouri; R U Thomas
Journal:  Br J Pharmacol       Date:  1981-10       Impact factor: 8.739

View more
  7 in total

1.  Thromboxane synthase immunohistochemistry in inflammatory bowel disease.

Authors:  E Carty; C Nickols; R M Feakins; D S Rampton
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

2.  Distinct roles of prostaglandin H synthases 1 and 2 in T-cell development.

Authors:  B Rocca; L M Spain; E Puré; R Langenbach; C Patrono; G A FitzGerald
Journal:  J Clin Invest       Date:  1999-05-15       Impact factor: 14.808

3.  The localization of thromboxane synthase in normal and pathological human kidney tissue using a monoclonal antibody Tü 300.

Authors:  R Nüsing; P M Fehr; F Gudat; E Kemeny; M J Mihatsch; V Ullrich
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

Review 4.  Prostaglandin terminal synthases as novel therapeutic targets.

Authors:  Shuntaro Hara
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2017       Impact factor: 3.493

Review 5.  The Biosynthesis of Enzymatically Oxidized Lipids.

Authors:  Ali A Hajeyah; William J Griffiths; Yuqin Wang; Andrew J Finch; Valerie B O'Donnell
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-19       Impact factor: 5.555

6.  Thromboxane A2 receptor is highly expressed in mouse immature thymocytes and mediates DNA fragmentation and apoptosis.

Authors:  F Ushikubi; Y Aiba; K Nakamura; T Namba; M Hirata; O Mazda; Y Katsura; S Narumiya
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

7.  Direct Molecular Fishing of New Protein Partners for Human Thromboxane Synthase.

Authors:  A V Svirid; P V Ershov; E O Yablokov; L A Kaluzhskiy; Yu V Mezentsev; A V Florinskaya; T A Sushko; N V Strushkevich; A A Gilep; S A Usanov; A E Medvedev; A S Ivanov
Journal:  Acta Naturae       Date:  2017 Oct-Dec       Impact factor: 1.845

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.